Released On: July 7, 2023 Valid for Credit Through: July 6, 2024 Target Audience This activity has been designed to meet the educational needs of neurologists, including neuroimmunologists; neuroradiologists; ophthalmologists, including neuro-ophthalmologists; and specialist neurology nurses involved in the management of NMOSD. Overview In this touchSATELLITE SYMPOSIUM activity, leading experts in neuromyelitis optica spectrum disorder …
Category Archives: Webinar/Video
Targeting Pathways of Disease Progression in Early Multiple Sclerosis
Released On: June 30, 2023 Valid for Credit Through: June 30, 2024 Credits Available for Physicians: Maximum of 1.50 AMA PRA Category 1 Credit(s)™ Target Audience and Goal Statement Neurologists, neuroscientists, nurse practitioners, neuroscience nurses and other healthcare professionals involved in the clinical study, management, and care of patients with multiple sclerosis. This CME activity will …
Continue reading “Targeting Pathways of Disease Progression in Early Multiple Sclerosis”
Deciphering Neuromyelitis Optica Spectrum Disorder: Addressing Real Clinician Questions Concerning Diagnosis and Management
Course opens: June 20, 2023Course expires: June 20, 2024 Overview Though neuromyelitis optica spectrum disorder (NMOSD) has had a specific lab marker (AQP4 antibody) for many years, its relapsing nature and overlapping syndromes still cause it to be confused with multiple conditions such as multiple sclerosis (MS), leading to inappropriate and even harmful treatment. The …
Contemporary Considerations in Multiple Sclerosis Treatment: A Post-Pandemic Educational Curriculum MedPoints™ in Multiple Sclerosis
This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants fromBiogen and Bristol Myers Squibb. Target Audience MS specialists, general neurologists, nursing professionals, pharmacists, PAs, and patient advocates in the care of people living with multiple sclerosis (MS). Faculty Robert …
Building Clinical Confidence: Evidence-based Care for People Living with MS
This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC)and Catamount Medical Education. This activity is supported by independent educational grants from Janssen Scientific Affairs, LLC and Sanofi. Target Audience Neurologists, primary care physicians, nurse practitioners, nurses, physician associates (PAs), rehabilitation specialists, mental health specialists, radiologists, and other clinicians who are part …
Continue reading “Building Clinical Confidence: Evidence-based Care for People Living with MS”
Contemporary Considerations in Multiple Sclerosis Treatment:
A Post-Pandemic Educational Curriculum
Release Date: January 10, 2023 Valid for Credit through: January 10, 2024 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants from Biogen and Bristol Myers Squibb. Target Audience MS specialists, general neurologists, nursing professionals, pharmacists, physician assistants, and …
Building Clinical Confidence: Evidence-based Care for People Living with MS
Released On: December 5, 2022 Expires On: December 5, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported by independent educational grants from Janssen Scientific Affairs, LLC and Sanofi. This activity can take up to 75 minutes to complete. Target Audience Neurologists, primary …
Continue reading “Building Clinical Confidence: Evidence-based Care for People Living with MS”
Collaborating Across the Continuum™: Managing Relapsing MS – A Focus on the Utility of CD20-Targeted B-Cell Therapy
Release Date: November 30, 2022 Expiration Date: November 30, 2023 Faculty: Stephen Krieger, MD, FAAN Jacci Bainbridge, PharmD, FCCP Denise Bruen, ANP-BC, MSN, MSCN Activity Overview Following the success of anti-CD20 antibodies in the treatment of multiple sclerosis (MS), there has been a shift in understanding of its pathophysiology. B cells have been identified as …
What Would You Do? An Interactive and Evidence-Based Educational Session on MS Treatment Approaches
Release Date: December 13, 2022 Valid for Credit through: December 13, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants fromBiogen and Genentech. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ Nurses — maximum of 1.0 contact …
Preventing Common Secondary Conditions in Advanced MS: A Focus on Urinary Tract Infections
Target Audience This activity has been designed to meet the educational needs of nursing professionals, physicians, advanced practice clinicians, social workers, and other members of the healthcare team involved in the management of patients with MS. Learning Objectives Upon completing this activity, participants should be better able to: Identify modifiable risk factors of urinary tract …